Stephens & Co. : The DermTech (DMTK.US) rating was reaffirmed and adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, with a target price of $1.50.
Stephens & Co.：重申DermTech(DMTK.US)评级，由持股观望调整至持股观望评级, 目标价1.50美元。
Stephens & Co. : The DermTech (DMTK.US) rating was reaffirmed and adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, with a target price of $1.50.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.